US Representative
Matthew Rosendale 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 13)
Legislative Session
Co-Sponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1974
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention-Wide Activities and Program Support for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1975
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Cancer Institute for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1976
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Heart, Lung, and Blood Institute for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1977
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institutes of Dental and Craniofacial Research for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1978
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1979
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Intitute of Neurological Disorders and Stroke for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1980
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Disease for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1981
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of General Medical Science for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1982
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1983
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Eye Institute for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1984
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Environmental Health Sciences for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1985
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Aging for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1986
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases for fiscal year 2024.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB1987
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Deafness and Other Communication Disorders for fiscal year 2024.
Cosponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB198
Introduced
2/27/23
Refer
2/27/23
Drug Pricing Transparency and Accountability Act This bill establishes a two-year moratorium on allowing new, non-rural hospitals and associated child sites to participate in the 340B drug pricing program; during the moratorium, the Department of Health and Human Services must issue regulations with specified program eligibility standards. The bill also requires additional reporting relating to program participation, eligibility, and costs.